SCHEMBL26109178

SCHEMBL26109178

Cn1c(C2=CCC3(CC2)CCN(C=CC=O)CC3)c(-c2cncc(F)c2)c2c(N)ncnc21

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.31
▸ FGFR2 P21802 1/20 0.31
▸ FGFR4 P22455 1/20 0.31
▸ FGFR3 P22607 1/20 0.31
▸ HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26109353 0.90 RET (0.32) —
SCHEMBL26109006 0.89 RIPK2 (0.35) FGFR1FGFR2FGFR4FGFR3
SCHEMBL26108781 0.89 BTK (0.35) FGFR1FGFR2FGFR4FGFR3
SCHEMBL26107398 0.87 — —
SCHEMBL26107955 0.87 RET (0.37) —
SCHEMBL26109533 0.87 KIT (0.35) FGFR1FGFR2FGFR4FGFR3
SCHEMBL26109211 0.85 PIK3CD (0.33) FGFR1FGFR2FGFR4FGFR3
SCHEMBL26106109 0.84 CCNT1 (0.34) HDAC4
SCHEMBL30582633 0.84 CCNT1 (0.34) HDAC4
SCHEMBL26108120 0.84 LRRK2 (0.32) FGFR1FGFR2FGFR4FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO claimed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback